We are the biospecimen and biomarker specialists™ Discovery Life Sciences combines the world’s largest biospecimen inventory and procurement network with preeminent multi-omic service laboratories to accelerate precision medicine programs for cancer, infectious disease, and other complex conditions. Our robust biospecimen and biomarker platform is optimized for speed and large-scale capacity. We routinely manage hundreds of studies and expertly test thousands of biospecimens simultaneously as a single vendor - eliminating time-consuming and inefficient transfers of biospecimens or data between different vendors. Leading biopharma, diagnostic and academic institutions trust us to quickly deliver high-quality biospecimens and reliable, reproducible biomarker data, so they can outpace their competition and push the leading edge of innovation. We accomplish this with a biobank of over 10 million biospecimens and hundreds of clinical sites that allow researchers to build bespoke study cohorts and seamlessly interrogate them using our CLIA certified, GLP compliant service laboratories, including our world-renowned sequencing and bioinformatics laboratory, HudsonAlpha Discovery, the expert IHC service laboratory that built the pembrolizumab companion diagnostic prototype, and extensive cell and flow cytometry facilities with GMP compliant leukapheresis products for cell therapy development and manufacturing. Visit www.dls.com to learn more.